Arrhythmias — Expert Clinical Reference

Internal Medicine · Clinical Specialties

How it begins

Expert clinical reference on electrophysiology, ECG diagnosis, bradyarrhythmias, supraventricular and ventricular tachyarrhythmias, hereditary syndromes, antiarrhythmics, implantable devices and management of cardiac arrest.

What it covers

1. Cardiac Arrhythmias
2. 1. Normal Cardiac Electrophysiology
3. · 1.1 Normal Driving System
4. · 1.2 Cardiac Action Potential
5. · 1.3 Fundamental Electrophysiological Properties
6. 2. Systematic ECG Interpretation
7. · 2.1 Fundamental Normal Values
8. · 2.2 Systematic ECG Reading — 8 Step Method
9. 3. Electrophysiological Mechanisms of Arrhythmias
10. · 3.1 Abnormal Automation
11. · 3.2 Triggered Activity
12. · 3.3 Reentry
13. 4. Sinus Node Dysfunction
14. · 4.1 SSE Manifestations
15. · 4.2 Diagnosis
16. 5. Atrioventricular Blocks (AVB)
17. · 5.1 First Degree AV Block
18. · 5.2 Second Degree AV Block
19. · 5.3 Third Degree AV Block (Complete AV Block)
20. 6. Branch Blocks and Hemiblocks
21. 7. Atrial Fibrillation — Comprehensive Management
22. · 7.1 Pathophysiology of AF
23. · 7.2 Score CHA₂DS₂-VASc — Indication for Anticoagulation
24. · 7.3 HAS-BLED Score — Hemorrhagic Risk
25. · 7.4 Oral Anticoagulation — NOAC vs. VKA
26. · 7.5 Cardioversion in AF
27. · 7.6 Frequency Control vs. Rhythm Control
28. · 7.7 Catheter Ablation in AF
29. 8. Headphone Flutter
30. 9. Paroxysmal Supraventricular Tachycardia (PSVT)
31. · 9.1 AV Nodal Reentry Tachycardia (AVRT)
32. · 9.2 Orthodromic Reentry Tachycardia via Accessory Route (TROA / TRAV)
33. · 9.3 Termination and Chronic Treatment of TPSV
34. 10. Atrial and Multifocal Tachycardia
35. · 10.1 Focal Atrial Tachycardia
36. · 10.2 Multifocal Atrial Tachycardia (MAT)
37. 11. Wolff-Parkinson-White (WPW) syndrome
38. · 11.1 WPW ECG in Sinus Rhythm
39. · 11.2 FA with WPW — Emergency
40. · 11.3 Risk Stratification and Definitive Treatment
41. 12. Ventricular Tachycardia
42. · 12.1 Differential Diagnosis Wide QRS Tachycardia
43. · 12.2 Sustained Monomorphic VT
44. · 12.3 Idiopathic VT (Structurally Normal Heart)
45. 13. Torsades de Pointes (TdP)
46. · 13.1 ECG Characteristics and Mechanism
47. · 13.2 Causes of Acquired TdP — QT Prolonging Drugs
48. · 13.3 Treatment of TdP
49. 14. Ventricular Fibrillation and Ventricular Flutter
50. 15. Brugada syndrome
51. · 15.1 ECG Diagnostic Criteria
52. · 15.2 Triggering and Modifying Factors
53. · 15.3 Risk Stratification and Treatment
54. 16. Congenital Long QT Syndrome (LQTS)
55. 17. Arrhythmogenic RV Cardiomyopathy (ARVC/ARVD)
56. 18. CPVT, Short QT and Other Syndromes
57. · 18.1 Polymorphic Catecholamine VT (CPVT / CPVT)
58. · 18.2 Short QT Syndrome (SQTS)
59. 19. Antiarrhythmics — Vaughan Williams Classification
60. · 19.1 Amiodarone — The Reference Antiarrhythmic
61. 20. Electrical Cardioversion and Defibrillation
62. · 20.1 Synchronized Electrical Cardioversion (CVE)
63. · 20.2 Defibrillation (Not Synchronized)
64. 21. Pacemaker, ICD and CRT
65. · 21.1 Permanent Pacemaker — NBG Code (NASPE/BPEG)
66. · 21.2 Implantable Automatic Defibrillator (ICD)
67. · 21.3 Cardiac Resynchronization Therapy (CRT)
68. 22. Advanced CPR — ACLS Algorithms 2020
69. · 22.1 Cardiorespiratory Arrest Algorithm: Defibrillatable Rhythms (VF/pulseless VT)
70. · 22.2 Post-Resuscitation Care
71. 23. Arrhythmias in Special Situations
72. · 23.1 Arrhythmias in AMI
73. · 23.2 Arrhythmias in Pregnancy
74. 24. Syncope of Arrhythmic Origin
75. · 24.1 Differential diagnosis by initial ECG
76. · 24.2 Syncope Risk Score — EGSYS (Evaluation of Guidelines in Syncope Study)
77. 25. Sudden Cardiac Death — Prevention
78. · 25.1 Causes of SCD according to age
79. · 25.2 Primary and Secondary Prevention